Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Precision medicine: the rifle vs. shotgun approach to cancer treatment

Hirva Mamdani, MD
Conditions
June 20, 2022
Share
Tweet
Share

Why does one person respond favorably to lung cancer treatment while another does not?

The answer lies in their DNA.

Just 20 years ago, lung cancer was broadly categorized into two groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Relatively recently, the treatment of NSCLC shifted from chemotherapy as a single treatment option to treatment with precision medicine, which is positively impacting survival rates.

Within the past ten years, researchers and clinicians started to understand biological differences between the two most common subtypes of NSCLC (adenocarcinoma and squamous cell carcinoma), which provided insight into why certain patients had greater success with treatment.

A breakthrough occurred when we discovered specific ‘driver’ gene mutations within the tumor, realized each lung cancer tumor is unique, and started developing medications specifically targeting these mutations. This was the beginning of precision medicine in treating lung cancer.

This discovery allowed us to transition from a “one size fits all” to a “custom made” approach to treatment, and those treatments are working. Treatment with targeted therapies has improved survival and quality of life for patients with advanced non-small-cell lung cancer.

Precision or personalized medicine has many benefits, but the greatest is that it allows patients to receive treatments most likely to work for them while reducing drug toxicity. Essentially, we can use the most effective tools at our disposal rather than deploying them all at once.

So, what’s the bad news?

Testing for common targetable gene mutations/alterations is becoming standard practice in oncology, but many cancer patients do not undergo comprehensive genomic testing. That means targetable mutated genes are often going unnoticed.

Even if a patient has genomic alterations not currently treatable with precision medicine, this advanced testing may provide clinicians with vital insight to rule out which therapies will not work or may potentially negatively impact the efficacy of other treatments. Additionally, while some alterations may not be targetable with an FDA-approved therapy at this time, clinical trials may provide additional future options.

Today, new treatment options are being developed from lifesaving clinical trials regularly. For example, last year, a new drug was approved to target a specific gene abnormality that is present in about 13 percent of lung cancers. This new option provided a fresh path for patients who may have otherwise run out of options. We know even more progress will be made through research and clinical trials.

We are making breakthroughs in cancer treatment every day, and our ability to treat patients more effectively will continue improving as precision medicine advances. I encourage all patients who are diagnosed with cancer to talk with their doctor about individualized treatments and comprehensive genomic testing. I also encourage patients to ask about clinical trials, which truly are the medicine of tomorrow.

We now have capabilities that allow us to better understand why every person responds to cancer differently. More importantly, we are constantly developing new tools that can provide unique treatments for every cancer journey. In time, targeted therapies will move us further toward a world free of cancer.

Hirva Mamdani is the leader of the Thoracic Oncology Multidisciplinary Team, a member of the Phase I Clinical-Pharmacology Program, and director of the Lung Cancer Screening Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI, an NCI-designated comprehensive cancer institute with 16 cancer treatment locations in Michigan and Ohio. She can be reached on Twitter @HirvaMamdani and on LinkedIn.

Image credit: Shutterstock.com

Prev

Utilization management is medicine's great conspiracy theory

June 20, 2022 Kevin 0
…
Next

Doctors are not the bad guys

June 20, 2022 Kevin 1
…

Tagged as: Oncology/Hematology

Post navigation

< Previous Post
Utilization management is medicine's great conspiracy theory
Next Post >
Doctors are not the bad guys

Related Posts

  • Hormone replacement therapy is still linked to cancer

    Martha Rosenberg
  • What’s barbaric in medicine?

    Lisa Masson, MD, MBA
  • The culture of permission in medicine

    Lauren Joseph
  • How social media can advance humanism in medicine

    Pooja Lakshmin, MD
  • Cancer care costs everyone too much. What can we do about it?

    Andrew Hertler, MD
  • How to avoid treatment you don’t need

    Marshall Allen

More in Conditions

  • The endless waves of chronic illness

    Michele Luckenbaugh
  • Surviving and thriving after life’s most difficult moments

    Rebecca Fogg, MBA
  • The surprising power of Play-Doh in pediatric care: How it’s bringing families together

    Alexander Rakowsky, MD
  • Lazarus: the dead man brought back to life

    William Lynes, MD
  • The psychoanalytic hammer: lessons in listening and patient-centered care

    Greg Smith, MD
  • 5 essential tips to help men prevent prostate cancer

    Kevin Jones, MD
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • The Titanic sinking: a metaphor for the impending collapse of medicine

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD & Shreekant Vasudhev, MD | Physician
  • Recent Posts

    • The Iranian diaspora’s fight for liberty: Overcoming challenges in the largest women’s rights movement of our century

      Montreh Tavakkoli, MD | Physician
    • Surviving clinical rounds: tips and tales from a pediatric hematologist-oncologist [PODCAST]

      The Podcast by KevinMD | Podcast
    • The harmful effects of shaming patients for self-education

      Maryanna Barrett, MD | Physician
    • The power of self-appreciation: Why physicians need to start acknowledging their own contributions

      Wendy Schofer, MD | Physician
    • The endless waves of chronic illness

      Michele Luckenbaugh | Conditions
    • Skydiving and surgery: How one doctor translates high-stress training to saving lives

      Alexandra Kharazi, MD | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Abortion Is Not Murder in the Eyes of the Law
  • Introducing Allergenic Foods Early Tied to a Reduction in Later Allergies
  • Isotretinoin REMS Still Needed, But Its Burden Could Be Reduced, FDA Staff Says
  • Children Do Well With Fewer Opiates After Surgery
  • High Out-of-Pocket Costs Tied to Less Follow-Up After Initial Mammography

Meeting Coverage

  • Children Do Well With Fewer Opiates After Surgery
  • Advances in Diagnosis and Management of Severe Cutaneous Adverse Reactions
  • Orismilast Clears Skin in Moderate-to-Severe Psoriasis
  • New Combinations Promising in Advanced Urothelial Carcinoma
  • No Survival Benefit With CRT Versus Chemo for Locally Advanced Endometrial Cancer
  • Most Popular

  • Past Week

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • What is driving physicians to the edge of despair?

      Edward T. Creagan, MD | Physician
    • Beyond the disease: the power of empathy in health care

      Nana Dadzie Ghansah, MD | Physician
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
  • Past 6 Months

    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • The Titanic sinking: a metaphor for the impending collapse of medicine

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD & Shreekant Vasudhev, MD | Physician
  • Recent Posts

    • The Iranian diaspora’s fight for liberty: Overcoming challenges in the largest women’s rights movement of our century

      Montreh Tavakkoli, MD | Physician
    • Surviving clinical rounds: tips and tales from a pediatric hematologist-oncologist [PODCAST]

      The Podcast by KevinMD | Podcast
    • The harmful effects of shaming patients for self-education

      Maryanna Barrett, MD | Physician
    • The power of self-appreciation: Why physicians need to start acknowledging their own contributions

      Wendy Schofer, MD | Physician
    • The endless waves of chronic illness

      Michele Luckenbaugh | Conditions
    • Skydiving and surgery: How one doctor translates high-stress training to saving lives

      Alexandra Kharazi, MD | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Precision medicine: the rifle vs. shotgun approach to cancer treatment
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...